Avisa Pharma Inc
We have developed the first, rapid, point of care test for pneumonia that provides for appropriate use of antibiotics to combat antibiotic resistant infections
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location Santa Fe, NM, USA
- Currency USD
- Founded October 2010
- Employees 6
- Incorporation Type C-corp
- Website avisapharma.com
Company Summary
Avisa is a venture-backed company developing and commercializing the first rapid, point-of-care breath test for the diagnosis of pulmonary infections.
The rise of antibiotic resistant infections costs the U.S. healthcare system over $20 billion each year. We are seeking $1,000,000 of a $3,000,000 Convertible Note financing of which $2,000,000 has been invested by current shareholders for runway expansion for $15 million Series B round underway.
Team
-
David S JosephPresident and CEO
Co-Founder of Avisa Pharma with 40 years of lifescience experience, co-founder and CEO of four lifescience companies in medical technology, biomaterials and biopharmaceuticals. Successful exits include two public companies and two acquisitions.
-
Graham S Timmins, Ph.D.Chief Science Advisor
Co-founder and Associate Professor, Pharmaceutical Sciences, University of New Mexico. Patented and developed Avisa's stable, non-radioactive isotope technology platform. Recipient of multiple federal grants, over 50 scientific publications.
-
Elizabeth A Perkett, MDChief Medical Officer
Former Professor of Pulmonary Medicine, Vanderbilt University, Cystic Former professor of pulmonary medicine, Vanderbilt University. Full time Avisa CMO, over 50 recent clinical publications.
-
Matt CullerVP Finance
Former investment bank analyst, venture partner and VP Finance and Operations of a clean tech company
-
VP Engineering and Product Management
20 years of medical device experience and laser spectoscopy
Advisors
-
Kate Shay, Duane Morris, PhiladelphiaUnconfirmed
Previous Investors
-
Sun Mountain Capital, Santa Fe, New MexicoUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.